The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Wave of FDA Warning Letters to Injectable Compounders in Q1 2014 Follows 2013 Inspection Blitz and Legislative Empowerment; Reci August 11, 2025: The FDA voices concern about sites that supply compounding ingredients Partnership for Safe Medicines FDA Moves to Reevaluate Several Peptides American Med Spa Association FDA to weigh easing limits on unproven peptides promoted by RFK Jr. FDA's confusing warning letters